ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,359Medicare Part D Prescriptions Filled, Including Refills

Rank: 77 out of 617

$537K Total Retail Price of All Prescriptions

Rank: 75 out of 617

344 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 344 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 344 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 9,050 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 661 572 1 2
HYDROCODONE-ACETAMINOPHEN 441 294 S3 2 8
LEVOTHYROXINE SODIUM 380 316 3 1
WARFARIN SODIUM 366 327 4 7
OMEPRAZOLE 356 275 5 3
METFORMIN HCL 282 215 6 9
AMLODIPINE BESYLATE 249 237 7 6
BUMETANIDE 213 180 8 124
LISINOPRIL 211 171 9 5
HYDROCHLOROTHIAZIDE 198 168 10 13
POTASSIUM CHLORIDE 193 171 11 10
FUROSEMIDE 177 147 12 4
ALLOPURINOL 171 163 13 27
GLIMEPIRIDE 166 132 14 33
CARVEDILOL 144 122 15 19
ZOLPIDEM TARTRATE 137 75 16 23
LOSARTAN POTASSIUM 137 124 16 22
CIPROFLOXACIN HCL 124 101 18 60
BISOPROLOL FUMARATE 123 102 19 100
GABAPENTIN 122 67 20 16
LANTUS 118 98 21 39
TAMSULOSIN HCL 115 94 22 26
METOPROLOL TARTRATE 114 68 23 11
MELOXICAM 113 105 24 24
CARBIDOPA-LEVODOPA 109 87 25 69
DONEPEZIL HCL 106 92 26 30
ATENOLOL 95 93 27 17
CITALOPRAM HBR 94 74 28 18
METOPROLOL SUCCINATE 93 88 29 12
SPIRIVA 92 89 30 61
VERAPAMIL ER 91 61 31 90
DILTIAZEM ER 91 91 31 81
TRICOR 88 75 33 83
BENAZEPRIL HCL 88 83 33 44
AMLODIPINE BESYLATE-BENAZEPRIL 87 63 35 80
CRESTOR 86 63 36 28
NEXIUM 83 58 37 43
ATENOLOL-CHLORTHALIDONE 83 70 37 142
ATORVASTATIN CALCIUM 75 66 39 14
ZETIA 72 69 40 77
ISOSORBIDE MONONITRATE ER 71 58 41 52
CEPHALEXIN 70 53 42 68
FLUOXETINE HCL 69 47 43 73
RAMIPRIL 68 68 44 67
ALENDRONATE SODIUM 67 53 45 25
BISOPROLOL-HYDROCHLOROTHIAZIDE 64 55 46 87
INSULIN SYRINGE 64 60 46 148
CLOPIDOGREL 63 44 48 53
ENALAPRIL MALEATE 62 46 49 34
PANTOPRAZOLE SODIUM 61 53 50 37
CELEBREX 60 60 51 63
ADVAIR DISKUS 59 54 52 38
PRAVASTATIN SODIUM 58 44 53 21
TRAMADOL HCL 57 39 54 15
OXYBUTYNIN CHLORIDE 53 38 55 88
PRAMIPEXOLE DIHYDROCHLORIDE 52 26 56 153
LANTUS SOLOSTAR 52 27 56 115
OXYBUTYNIN CHLORIDE ER 51 38 58 114
SERTRALINE HCL 51 39 58 20
DIGOXIN 51 41 58 48
SPIRONOLACTONE 50 40 61 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.